Sengenics: Yvonne Linney
Yvonne Linney has been appointed to the board of directors of immuno-proteomics firm Sengenics as a new independent director. Previously, she held executive roles at Agilent Technologies Life Science Group and Amersham International (GE Healthcare). More recently, she held CEO and chief operating officer positions at Transcriptic (Strateos) and Artificial. Linney is also a director at Bionano Genomics.